{
  "id": 8210978,
  "title": "Dr Reddy’s to distribute India’s first dengue vaccine Qdenga in 2027",
  "url": "https://urgent.news/2026/09/18/dr-reddys-to-distribute-indias-first-dengue-vaccine-qdenga-in-2027",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-18T08:43:43.000Z",
  "source": {
    "name": "The Indian Express",
    "slug": "the-indian-express",
    "url": "https://indianexpress.com/article/health-wellness/degue-vaccine-qdenga-2027-india-first-distribute-dr-reddy-10883543/"
  },
  "original_language": "en",
  "account": "India's first approved dengue vaccine, Qdenga, is set to be distributed by Dr Reddy's Laboratories in the private market starting from the first half of 2027. This announcement comes after Takeda Pharmaceutical Company and Dr Reddy's Laboratories reached an exclusive collaboration agreement, with Dr Reddy's taking on the responsibility of promoting and distributing the vaccine across India's private sector for both pediatric and adult populations. The Central Drugs Standard Control Organisation (CDSCO) had granted Qdenga marketing authorization to individuals aged 4 to 60 years in July 2026. The vaccine is significant due to its ability to protect against all four dengue virus serotypes - DENV-1, DENV-2, DENV-3, and DENV-4, which are prevalent across multiple regions in India. Clinical trials have shown an efficacy rate of 61.2% against virologically confirmed dengue and 84.1% against dengue-related hospitalization at 4.5 years after vaccination. The vaccine is administered as a two-dose regimen, with each dose being 0.5 mL and being given subcutaneously, three months apart. The two doses are given three months apart. Qdenga is expected to be available in India after the completion of required processes such as obtaining Registration Certificate and Import Licence, quality-release processes, and commercial distribution.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "The Economic Times",
        "title": "Dr Reddy’s to sell dengue vax in India from 2027",
        "url": "https://urgent.news/2026/09/18/dr-reddys-to-sell-dengue-vax-in-india-from-2027",
        "published": "2026-09-18T03:48:19.000Z"
      },
      {
        "outlet": "Business Standard IN",
        "title": "Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine",
        "url": "https://urgent.news/2026/09/18/dr-reddys-signs-india-distribution-deal-for-takedas-qdenga-dengue",
        "published": "2026-09-18T04:53:22.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "Dr Reddy’s to distribute Takeda’s dengue vaccine in India",
        "url": "https://urgent.news/2026/09/18/dr-reddys-to-distribute-takedas-dengue-vaccine-in-india",
        "published": "2026-09-18T07:44:34.000Z"
      },
      {
        "outlet": "The Hindu Health",
        "title": "Dr. Reddy's, Takeda Pharma ink pact to distribute India's first dengue vaccine QDENGA",
        "url": "https://urgent.news/2026/09/18/dr-reddys-takeda-pharma-ink-pact-to-distribute-indias-first-dengue",
        "published": "2026-09-18T09:22:52.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}